These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2841022)

  • 1. Cisplatin and carboplatin in combination with etoposide as a treatment for non-small cell lung cancer: the experience of the EORTC Lung Cancer Working Party.
    Klastersky J
    Cancer Treat Rev; 1988 Jun; 15 Suppl B():33-40. PubMed ID: 2841022
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party.
    Klastersky J; Sculier JP; Dabouis G; Bureau G; Libert P; Ravez P; Vandermoten G; Thiriaux J; Lecomte J; Cordier R
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):20-4. PubMed ID: 2154855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.
    Klastersky J; Sculier JP; Lacroix H; Dabouis G; Bureau G; Libert P; Richez M; Ravez P; Vandermoten G; Thiriaux J
    J Clin Oncol; 1990 Sep; 8(9):1556-62. PubMed ID: 2167953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carboplatin-Vepeside in the treatment of non-small cell bronchial cancers. A phase II study].
    Heckmayr M; Gatzemeier U; Hossfeld DK; Achterrath W
    Pneumologie; 1990 Feb; 44 Suppl 1():588-9. PubMed ID: 2164205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy in non-small cell bronchial carcinoma. 12 years' experience in an international cooperative group: EORTC Lung Cancer Working Party].
    Lacroix H; Sculier JP
    Bull Cancer; 1990; 77(10):997-1005. PubMed ID: 2174277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Carboplatin replace Cisplatin in small cell lung cancer?
    Noronha V
    Indian J Cancer; 2011; 48(4):452-3. PubMed ID: 22293259
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
    Figlin RA; Crowley JJ; Jacobs EL; Muirhead M; Goodwin JW; Rinehart JJ; Livingston RB
    Cancer; 1996 Sep; 78(5):998-1003. PubMed ID: 8780537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-finding studies with carboplatin, ifosfamide, etoposide, and mesna in non-small cell lung cancer.
    van Zandwijk N; ten Bokkel Huinink WW; Wanders J; Simonetti G; Dubbelman R; Franklin H; van Tinteren H; McVie JG
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):16-9. PubMed ID: 2154854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of small cell bronchial cancer with a combination of carboplatin, vincristine and etoposide].
    Gatzemeier U; Achterrath W; Heckmayr M; Hossfeld DK; Neuhauss R; Reck M; Zschaber R
    Pneumologie; 1990 Feb; 44 Suppl 1():584-5. PubMed ID: 2164203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide.
    Belani CP; Egorin MJ; Abrams JS; Hiponia D; Eisenberger M; Aisner J; Van Echo DA
    J Clin Oncol; 1989 Dec; 7(12):1896-902. PubMed ID: 2555452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II studies with carboplatin in non-small cell lung cancer.
    Gatzemeier U; Heckmayr M; Neuhauss R; Hossfeld D; Achterrath W; Lenaz L
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):25-31. PubMed ID: 2154856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
    Comella P; Scoppa G; Daponte A; Musetta G; Anania C; Maiorino A; Curcio C; Casaretti R; Comella G
    Cancer; 1994 Oct; 74(7):1874-81. PubMed ID: 8082093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.
    Klastersky J; Sculier JP; Bureau G; Libert P; Ravez P; Vandermoten G; Thiriaux J; Lecomte J; Cordier R; Dabouis G
    J Clin Oncol; 1989 Aug; 7(8):1087-92. PubMed ID: 2547028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy with cisplatin and etoposide for non-small-cell lung cancer.
    Klastersky J
    Semin Oncol; 1986 Sep; 13(3 Suppl 3):104-14. PubMed ID: 3020693
    [No Abstract]   [Full Text] [Related]  

  • 15. Carboplatin (JM8) as a single agent and in combination in the treatment of small cell lung cancer.
    Smith IE; Evans BD
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():73-5. PubMed ID: 3002624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of therapeutic trials of carboplatin in lung cancer.
    Bunn PA
    Semin Oncol; 1989 Apr; 16(2 Suppl 5):27-33. PubMed ID: 2541506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer.
    Perez EA; Gandara DR
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):2-5. PubMed ID: 8209273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: relation of the in vitro chemosensitive test to clinical response.
    Higashiyama M; Kodama K; Yokouchi H; Takami K; Nakagawa H; Imamura F; Minamigawa K; Kobayashi H
    Oncol Rep; 2001; 8(2):279-83. PubMed ID: 11182040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase II study of a novel combination regimen composed of cisplatin, carboplatin and etoposide against unresectable non-small cell lung cancer].
    Sakurai M; Ichiki M; Ohashi Y; Hayashi I
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):499-502. PubMed ID: 8383950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin plus etoposide in advanced non-small cell lung cancer patients age of 70 years or older.
    Kanat O; Evrensel T; Demiray M; Kurt E; Gonullu G; Arslan M; Manavoglu O; Ozkan A
    Lung Cancer; 2003 Aug; 41(2):233-4. PubMed ID: 12871788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.